Shockwave Competitors

Delisted . USA . 
Stock . Shockwave Medical
SWAVDelisted Stock  USD 268.45  6.44  2.34%   
Shockwave Medical competes with Inari Medical, Outset Medical, Clearpoint Neuro, Inspire Medical, and Penumbra; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Shockwave Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Shockwave Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Shockwave Medical competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
268.45268.45268.45
Details
Intrinsic
Valuation
LowRealHigh
234.04234.04295.30
Details
Naive
Forecast
LowNextHigh
277.65277.65277.65
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
262.80283.05303.30
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Shockwave Medical. Your research has to be compared to or analyzed against Shockwave Medical's peers to derive any actionable benefits. When done correctly, Shockwave Medical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Shockwave Medical.

Shockwave Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Shockwave Medical and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Shockwave and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Shockwave Medical does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
PEN
+ 0.86
NARI
MASI
+ 0.77
PEN
MASI
+ 0.73
PODD
PEN
+ 0.67
OM
MASI
+ 0.66
OM
ALGN
+ 0.65
TMDX
  
High negative correlations   
MASI
- 0.85
TMDX
TMDX
- 0.85
PEN
TMDX
- 0.76
NARI
TMDX
- 0.74
PODD
ALGN
- 0.58
PEN
PEN
- 0.55
INSP

Risk-Adjusted Indicators

There is a big difference between Shockwave Stock performing well and Shockwave Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Shockwave Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Shockwave Medical Competitive Analysis

The better you understand Shockwave Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Shockwave Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Shockwave Medical's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
SWAV NARI OM CLPT INSP PEN PODD TMDX MASI ALGN
 2.34 
 268.45 
Shockwave
 0.18 
 49.66 
Inari
 10.26 
 0.84 
Outset
 6.76 
 11.84 
Clearpoint
 1.36 
 188.73 
Inspire
 1.81 
 244.84 
Penumbra
 0.35 
 262.93 
Insulet
 4.16 
 76.04 
TransMedics
 2.27 
 172.96 
Masimo
 1.02 
 225.89 
Align
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Dangerous
Somewhat reliable
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
Modest
Modest
Weak
Very Weak
OK
Solid
Very Weak
Solid
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Low
High
Low
Below Average
Very Small
Very Low
Below Average
Very Low
Very Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Over Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Strong Buy
Buy
Strong Buy
Strong Buy
Strong Buy
Strong Buy
Strong Buy
Buy
Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Strong Sell
Cautious Hold
Strong Sell
Strong Hold
Buy
Strong Sell
Strong Buy
Strong Hold
Current Ratio
5.32
10.04
6.24
10.33
5.62
4.93
4.69
12.11
2.1
1.38
Net Asset
1.57 B
674.24 M
313.8 M
42.66 M
676.81 M
1.56 B
2.59 B
706.05 M
3.04 B
6.08 B
Profit Margin
0.21
-0.14
-1.23
-0.6
0.0437
0.0297
0.21
0.0814
0.0385
0.11
EBITDA
176.35 M
7.11 M
(153.79 M)
(20.99 M)
(40.27 M)
112 M
323.6 M
(7.6 M)
236.7 M
643.34 M
Operating Margin
0.19
-0.0434
-0.83
-0.64
0.0705
0.12
0.16
0.0361
0.0597
0.17
Current Valuation
12.32 B
2.83 B
66.4 M
288.04 M
5.15 B
9.17 B
19.19 B
2.78 B
9.53 B
15.8 B
Price To Book
18.38
6.7
0.84
10.55
7.95
8.36
16.73
12.34
6.04
4.24
Retained Earnings
110.47 M
(48.49 M)
(961.75 M)
(172.46 M)
(345.42 M)
134.86 M
(378 M)
(503.7 M)
1.8 B
2.45 B
Current Asset
N/A
N/A
N/A
8.1 M
167.55 M
244.36 M
190.76 M
N/A
299.14 M
732.01 M
Five Year Return
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Beta
0.88
0.96
1.95
1.11
1.36
0.51
1.22
2.07
0.97
1.65
Number Of Employees
1.47 K
1.3 K
480
107
1.01 K
4.2 K
3 K
584
3.8 K
21.69 K
Shares Outstanding
37.54 M
58.54 M
52.54 M
27.58 M
29.97 M
38.38 M
70.14 M
33.56 M
53.54 M
74.65 M
Cash Flow From Operations
196.05 M
35.93 M
(131.37 M)
(13.72 M)
24.65 M
97.33 M
145.7 M
(13.03 M)
94.1 M
785.78 M
Annual Yield
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Debt
770.61 M
32.05 M
136.19 M
13.94 M
24.85 M
234.34 M
1.45 B
515.95 M
970 M
126.62 M
Return On Equity
0.25
-0.18
-1.41
-0.68
0.0533
0.0313
0.49
0.19
0.0574
0.11
Return On Asset
0.0868
-0.0321
-0.27
-0.28
0.0118
0.0333
0.0757
0.0284
0.0266
0.067
Number Of Shares Shorted
1.83 M
3.69 M
3.35 M
687.56 K
1.95 M
2.26 M
2.84 M
8.43 M
3.35 M
2.9 M
Book Value Per Share
20.04
7.44
0.91
1.05
23.25
28.79
15.94
6.26
27.33
52.76
Current Liabilities
N/A
N/A
N/A
1.85 M
64.84 M
28.15 M
65.16 M
N/A
132.63 M
271.67 M
Total Asset
1.57 B
674.24 M
313.8 M
42.66 M
676.81 M
1.56 B
2.59 B
706.05 M
3.04 B
6.08 B
Debt To Equity
0.16
0.069
0.13
0.28
0.14
0.23
3.34
0.36
0.83
0.032
Short Ratio
2.24
3.79
5.78
3.36
5.07
6.26
6.54
4.06
4.49
3.32
Target Price
324.27
63.0
3.29
16.33
239.87
235.07
274.76
122.22
166.52
261.24
Last Dividend Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
98.72
95.4
55.14
30.53
98.06
93.42
99.66
96.83
94.73
89.55
Market Capitalization
12.57 B
2.91 B
39.95 M
305.91 M
5.58 B
9.23 B
18.38 B
2.66 B
9.05 B
17.04 B
Price To Earning
178.55
275.35
N/A
-3.36
15.29
191.13
N/A
N/A
35.69
29.97
Price To Earnings To Growth
1.38
-1.88
0.06
-0.46
-2.57
-62.27
4.03
N/A
4.73
1.31
Price To Sales
16.83
5.07
0.35
10.05
7.38
7.93
9.26
6.64
4.43
4.3
Net Income
147.28 M
(1.64 M)
(172.8 M)
(22.09 M)
(21.15 M)
90.95 M
206.3 M
(25.03 M)
81.5 M
445.05 M
Earnings Per Share
4.25
-1.35
-2.74
-0.69
1.11
0.87
5.86
0.93
1.45
5.86
Shares Owned By Insiders
1.19
8.75
2.11
7.83
1.94
3.86
0.34
3.17
8.18
6.6
Revenue
730.23 M
493.63 M
130.38 M
23.95 M
624.8 M
1.06 B
1.7 B
241.62 M
2.05 B
3.86 B
Working Capital
1.12 B
159.22 M
235.9 M
28.74 M
515.63 M
764.26 M
1.13 B
455.72 M
668.1 M
380.01 M
Cash And Equivalents
224.91 M
330.5 M
227.52 M
45.14 M
196.32 M
69.86 M
708.6 M
204.46 M
218 M
1.09 B
Cash Per Share
6.26
6.19
4.71
1.84
7.1
5.39
10.21
6.41
4.15
13.96
Gross Profit
424.74 M
338.96 M
17.83 M
13.53 M
341.74 M
535.21 M
805.6 M
65.27 M
1.06 B
2.64 B
Day Typical Price
270.21
49.87
0.83
11.56
188.63
242.66
262.38
75.2
172.13
224.17
Accumulation Distribution
0.0421
12776.6
98109.51
24020.73
12009.3
7491.83
8551.11
141938.0
31263.36
46340.29
Market Facilitation Index
11.65
0.0
N/A
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Daily Balance Of Power
(0.55)
(0.08)
0.4875
0.8621
0.5226
0.5967
0.1883
(0.79)
0.73
(0.17)
Period Momentum Indicator
(6.44)
(0.09)
0.078
0.75
2.54
4.35
0.93
(3.30)
3.84
(2.32)
Rate Of Daily Change
0.98
1.0
1.1
1.07
1.01
1.02
1.0
0.96
1.02
0.99
Day Median Price
271.09
49.98
0.82
11.43
188.58
241.57
262.1
74.78
171.71
223.31
Price Action Indicator
(5.86)
(0.37)
0.057
0.79
1.42
5.45
1.3
(0.38)
3.17
1.42
Coefficient Of Variation
3794.78
2911.97
1859.24
(10,136)
8690.17
706.46
371.32
(483.29)
471.6
(11,316)
Mean Deviation
1.68
2.31
5.04
2.79
2.11
1.78
1.35
3.06
1.6
1.85
Jensen Alpha
0.0257
0.0772
0.3217
(0.22)
(0.15)
0.299
0.517
(1.25)
0.362
(0.18)
Total Risk Alpha
(0.27)
(0.33)
(0.56)
(0.54)
(0.37)
0.0172
0.2692
(1.70)
0.185
(0.33)
Sortino Ratio
(0.02)
0.0023
0.0481
N/A
(0.03)
0.1142
0.3725
N/A
0.2728
N/A
Downside Variance
4.35
5.97
32.48
N/A
7.15
4.28
1.34
N/A
2.12
N/A
Standard Deviation
2.46
3.35
7.14
3.81
3.01
2.44
2.01
5.0
2.39
2.27
Kurtosis
4.16
6.43
2.88
2.38
2.43
1.85
6.23
16.57
5.77
0.1753
Potential Upside
3.76
6.3
15.09
6.89
4.95
4.63
3.36
4.04
4.84
3.07
Treynor Ratio
0.1869
0.3755
0.7135
(0.03)
0.0143
0.9118
3.68
(0.51)
0.3673
(0.02)
Maximum Drawdown
16.22
19.78
37.2
24.8
16.85
12.89
12.33
39.98
14.35
10.02
Variance
6.07
11.22
50.92
14.54
9.05
5.96
4.04
24.98
5.71
5.15
Market Risk Adjusted Performance
0.1969
0.3855
0.7235
(0.02)
0.0243
0.9218
3.69
(0.50)
0.3773
(0.01)
Risk Adjusted Performance
0.027
0.0339
0.05
5.0E-4
0.0162
0.1148
0.2116
(0.15)
0.1685
(0.0001)
Skewness
0.9829
1.89
1.33
0.1084
0.8743
0.5016
1.99
(2.87)
1.91
0.4897
Semi Deviation
2.04
2.35
5.04
N/A
2.59
1.95
0.6564
N/A
1.1
N/A
Information Ratio
(0.02)
0.0017
0.0384
(0.04)
(0.02)
0.0967
0.2148
(0.23)
0.1662
(0.06)
Value At Risk
(3.16)
(4.23)
(9.23)
(4.61)
(5.08)
(2.90)
(1.72)
(7.44)
(2.30)
(3.18)
Expected Short fall
(1.98)
(2.74)
(6.79)
N/A
(2.29)
(2.13)
(1.69)
N/A
(2.01)
N/A
Downside Deviation
2.09
2.44
5.7
N/A
2.67
2.07
1.16
N/A
1.46
N/A
Semi Variance
4.17
5.53
25.42
N/A
6.71
3.79
0.4308
N/A
1.21
N/A

Shockwave Medical Competition Performance Charts

Five steps to successful analysis of Shockwave Medical Competition

Shockwave Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Shockwave Medical in relation to its competition. Shockwave Medical's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Shockwave Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Shockwave Medical's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Shockwave Medical, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Shockwave Medical position

In addition to having Shockwave Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Copper Thematic Idea Now

Copper
Copper Theme
Companies involved in production of copper. The Copper theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Copper Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Consideration for investing in Shockwave Stock

If you are still planning to invest in Shockwave Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Shockwave Medical's history and understand the potential risks before investing.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bonds Directory
Find actively traded corporate debentures issued by US companies
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY